Zai Lab Ltd Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Zai Lab Ltd quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2021 to Q3 2024.
  • Zai Lab Ltd Share-based Payment Arrangement, Expense for the quarter ending September 30, 2024 was $16.8M, a 23.6% decline year-over-year.
  • Zai Lab Ltd Share-based Payment Arrangement, Expense for the twelve months ending September 30, 2024 was $73.9M, a 1.13% decline year-over-year.
  • Zai Lab Ltd annual Share-based Payment Arrangement, Expense for 2023 was $79.6M, a 29.9% increase from 2022.
  • Zai Lab Ltd annual Share-based Payment Arrangement, Expense for 2022 was $61.3M, a 50.6% increase from 2021.
  • Zai Lab Ltd annual Share-based Payment Arrangement, Expense for 2021 was $40.7M, a 64% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $73.9M $16.8M -$5.2M -23.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-12
Q2 2024 $79.1M $18.6M -$1.87M -9.13% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $81M $18M +$1.32M +7.92% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-08
Q4 2023 $79.6M $20.5M +$4.91M +31.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-27
Q3 2023 $74.7M $22M +$2.89M +15.1% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-12
Q2 2023 $71.8M $20.5M +$6.29M +44.2% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $65.6M $16.7M +$4.25M +34.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-08
Q4 2022 $61.3M $15.6M Oct 1, 2022 Dec 31, 2022 10-K 2024-02-27
Q3 2022 $19.1M +$8.55M +81% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $14.2M +$3.99M +39% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-07
Q1 2022 $12.4M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 $10.6M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $10.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.